UNHG

Current Thesis

UNHG is a 2x DAILY-reset leveraged ETF on UnitedHealth Group (UNH), launched 2025-07-22 near the depths of UNH's 2025 collapse. The tradeable narrative is the managed-care MARGIN RECOVERY: UNH cratered through 2025 (Brian Thompson murder Dec-2024, Witty resignation May-2025, DOJ probe, Medicare Advantage cost blowout), bottomed ~[entry redacted] and has re-rated to [entry redacted] (2026-06-03), roughly +50% off the lows. Q1 2026 (reported 2026-04-21) confirmed the turn — EPS $7.23 vs $6.56 est, MCR 83.9% vs 84.8% YoY, FY guide raised to >$18.25 adj EPS. BUT the obvious leg is largely spent: analyst avg PT $403.69 is only +1.8% over spot, Berkshire fully exited in May-2026, and the stock is stalling near $377 as lawsuit headlines resurface (2026-06-04). This is a MATURING recovery, not an accelerating narrative — and UNHG's daily-rebalance volatility decay makes it a swing/momentum vehicle, never a hold.

Bull Case

• Margin recovery is real and ahead of plan. Q1-2026 (2026-04-21) MCR 83.9% vs 84.8% Q1-2025; UnitedHealthcare operating margin expanded to 6.6%. EPS $7.23 beat $6.56 est; revenue $111.72B beat $109.57B est.
• Guidance raised, not cut. Management lifted FY2026 to >$18.25 adj EPS (2026-04-21); consolidated MCR guided 88.8% ±50bp, improving 30bp vs 2025's 89.1% on enterprise-wide repricing.
• Self-help lever intact. UNH ruthlessly shed ~965k unprofitable Medicare Advantage seniors + ~220k Medicaid members to rescue margin — a controllable lever that carries into 2027 repricing.
• Sell-side still carries upside targets. Truist $440, Bernstein $492 (~27% upside) as of early-Jun-2026; 28-analyst avg rating "Buy."
• Capital-return confidence. Quarterly dividend raised 5% to $2.32 (May-2026 AGM) — management leaning in, not retrenching.
• 2x leverage pays fast on a real UNH breakout. UNHG +10.27% on 2026-06-04 alone (UNH ~+5% day) — when UNH actually trends, the leveraged proxy compounds intraday.

Bear Case

• The easy money is made. UNH +~50% off 2025 lows to $377; analyst avg PT $403.69 is only +1.8% over spot — consensus thinks it's roughly fair value.
• Berkshire fully EXITED in May-2026 — bought ~Aug-2025, dumped the entire stake inside a year. That is smart-money distribution, not accumulation, at exactly this level.
• DOJ criminal + civil probe is an open overhang. Investigating MA diagnosis-coding, Optum Rx, and physician reimbursement; a Senate report calls the practices "aggressive gaming." Binary headline risk with no resolution date.
• Lawsuit risk re-surfacing. UNH stalling near $377 on 2026-06-04 as litigation headlines return (cryptonomist 2026-06-04).
• Recovery was bought with shrinkage. Margin was rescued by shedding ~1.2M members — great for MCR, poor for the top-line growth a momentum book wants to ride.
• Structural decay. UNHG resets 2x daily — in a sideways/choppy tape (exactly what a stalled $377 looks like) volatility drag bleeds the ETF even when UNH is roughly flat, on top of the ~0.77% expense ratio.

Setup & Price Structure

• UNHG $20.93 (2026-06-04 close), +10.27% on the day; 52-wk range $9.15–$25.42. Off its $9.15 low it has more than doubled, but still sits ~18% below the $25.42 high.
• Underlying UNH $377 (2026-06-03), intraday range $376.46–$387.46. The 2026-06-04 pop is a breakout ATTEMPT off the ~$360–377 stall zone, not a confirmed trend.
• AUM ~$116.8M, ~6.16M shares outstanding, ~1.73M shares daily volume — liquid enough to trade with tight spreads.
• Structure read: UNH is MATURING off a V-recovery. It is NOT stretched 50% above its MA in a mania; it is grinding/stalling near consensus fair value with a one-day momentum spark. For a 2x daily-decay proxy, a stalling tape is a low-quality holding environment.

Catalyst Calendar (next 30 days)

• No hard binary inside the 30-day window (2026-06-04 → ~2026-07-04). The 2026-06-04 lawsuit-headline + the ~+5% UNH day are the live tape, not scheduled events.
• Healthcare investor-conference season (Jun-2026, est.) — managed-care commentary at sell-side confs can swing sentiment; watch for UNH/Optum updates.
• ~2026-07-04 → 2026-07-28: quiet run-in to the print.
• 2026-07-28 — UNH Q2 2026 earnings (the real binary, just OUTSIDE the 30d window). Consensus EPS ~$4.84, revenue ~$110.83B. This is THE event that re-rates or breaks the recovery thesis. Treat ~2026-07-23 onward as an earnings blackout for fresh leveraged entries.

What Would Change Our Mind

• Bullish re-accelerate: UNH weekly close above $390 on volume with peer insurers (ELV, CVS, CI, HUM, CNC) confirming → recovery narrative re-fires from MATURING toward a fresh leg; UNHG becomes a swing-long probe.
• Thesis break / exit: UNH weekly close below $345 (recovery-leg structure break); OR Q2 print (2026-07-28) shows MCR back above 89% or FY adj-EPS guide cut below $18.25; OR DOJ files formal charges. Any one of these makes the leveraged proxy uninvestable.
• Decay tell: if UNH chops sideways $360–385 for 2+ weeks, UNHG bleeds regardless — exit the wrapper even if you would still hold the underlying stock.

Correlation Notes

• UNHG = 2x UNH with full single-name concentration — there is zero diversification; it IS UnitedHealth with double beta and daily volatility decay.
• Tracks the managed-care cohort: ELV, CVS, CI, HUM, CNC. A sector-wide MA cost-trend shock or DOJ/CMS policy headline hits all of them; UNH is the bellwether that leads the group in both directions.
• Sensitive to the "MA cost-trend" macro: rising senior utilization or unfavorable CMS rate notices pressure the entire group.
• Within our book this is a HEALTHCARE-ROTATION sleeve, largely uncorrelated to the AI/semis/quantum momentum names — useful as a non-tech diversifier, but only when the recovery is actually trending, not stalling into a leveraged-decay grind.